<DOC>
	<DOCNO>NCT02292433</DOCNO>
	<brief_summary>Study B1621018 ass Safety , Tolerability , Pharmacokinetics , Pharmacodynamics Two Dose Levels Pf-04937319 Japanese Subjects Type 2 Diabetes Mellitus As Monotherapy</brief_summary>
	<brief_title>A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients type 2 diabetes , diet/exercise therapy background therapy 1 oral antidiabetic agent ( exclude Actos ) Patients cardiovascular event Patients diabetic complication Female subject pregnant plan become pregnant Subjects unstable medical condition ( eg , hypertension )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>monotherapy</keyword>
	<keyword>PF-04937319</keyword>
</DOC>